Compare that to STEP 1 at 14.9% mean weight loss over 68 weeks, or SURMOUNT-1 at 20.9% over 72 weeks for the 15 mg tirzepatide dose
Advances on natural polyphenols as anticancer agents for skin cancer
The STEP 2 trial, conducted in patients with type 2 diabetes, demonstrated even greater triglyceride reductions (averaging 20-25%), likely reflecting the baseline metabolic dysfunction in this population
Lee, Effects of incretin-based therapeutic agents including tirzepatide on renal outcomes in patients with type 2 Diabetes: a systematic review and meta-analysis
Heres the core of the issue
The mesolimbic dopamine system, often called the brains reward pathway, plays a central role in addiction development and maintenance across virtually all substances of abuse